Circulating lipocalin-2 and retinol-binding protein 4 are associated with intima-media thickness and subclinical atherosclerosis in patients with type 2 diabetes
about
Retinol binding protein 4 in relation to diet, inflammation, immunity, and cardiovascular diseasesAssociation of lipocalin-2 level, glycemic status and obesity in type 2 diabetes mellitusSerum levels of retinol-binding protein-4 are associated with the presence and severity of coronary artery disease.Metabolically protective cytokines adiponectin and fibroblast growth factor-21 are increased by acute overfeeding in healthy humansA systematic analysis of human lipocalin family and its expression in esophageal carcinoma.Expression of retinol binding protein 4 and nuclear factor-κB in diabetic rats with atherosclerosis and the intervention effect of pioglitazone.Long-term effects intensive medical therapy on the development and progression of subclinical atherosclerosis and the metabolic syndrome in Chinese patients with type 2 diabetes mellitus.Serum lipocalin-2 levels are positively associated with not only total body fat but also visceral fat area in Chinese men.Assessment of lipocalin 2, clusterin, soluble tumor necrosis factor receptor-1, interleukin-6, homocysteine, and uric acid levels in patients with psoriasis.Mechanism and clinical evidence of lipocalin-2 and adipocyte fatty acid-binding protein linking obesity and atherosclerosis.The triad psoriasis-obesity-adipokine profile.Measuring non-polyaminated lipocalin-2 for cardiometabolic risk assessment.Retinol-binding protein-4 and hs-CRP levels in patients with migraine.Effect of curcumin on inhibiting atherogenesis by down-regulating lipocalin-2 expression in apolipoprotein E knockout mice.Plasmatic retinol-binding protein 4 and glial fibrillary acidic protein as biomarkers to differentiate ischemic stroke and intracerebral hemorrhage.Involvement of RBP4 in Diabetic Atherosclerosis and the Role of Vitamin D Intervention
P2860
Q28082224-145A48B3-63DE-4379-8723-5F499C96A691Q33909713-DAB4A90E-6495-4512-B75B-57B242698B69Q34145836-1E2DAD81-66F8-43AA-9166-D3129ADE94E5Q35036783-0BA83299-4007-49E3-AC51-CB94E3CBF811Q35804193-756191C2-F843-44C0-9C23-5734C50167A2Q37108738-63EF0437-D66E-48D8-97B6-1622EEDA3A5FQ37432907-B7B735CD-2BDD-4614-9B60-C4A21B1D8A4FQ37605558-53F13BC2-5AEB-4599-ABD9-7B21785B0EC7Q37718876-46E2EB29-AAAA-4799-980C-D45BAC2BF83DQ38161454-26407F24-EAD8-4110-B399-10AE65CFFB98Q38845553-F276EDB7-84F6-4917-8FE3-1EFED1624116Q47386642-AB3D5B8F-21D4-4895-83FD-B939A90D1B58Q49052306-C9984E78-5576-4A91-BEAD-D6578EF09B17Q51124413-0B8190C4-1DE8-403F-B258-8BA58C85449DQ52147247-8EBC5144-00D4-47EF-9A87-2C357F518412Q58773048-96CF102E-4B94-4C71-B39F-A524AED62260
P2860
Circulating lipocalin-2 and retinol-binding protein 4 are associated with intima-media thickness and subclinical atherosclerosis in patients with type 2 diabetes
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Circulating lipocalin-2 and re ...... patients with type 2 diabetes
@ast
Circulating lipocalin-2 and re ...... patients with type 2 diabetes
@en
type
label
Circulating lipocalin-2 and re ...... patients with type 2 diabetes
@ast
Circulating lipocalin-2 and re ...... patients with type 2 diabetes
@en
prefLabel
Circulating lipocalin-2 and re ...... patients with type 2 diabetes
@ast
Circulating lipocalin-2 and re ...... patients with type 2 diabetes
@en
P2093
P2860
P50
P1433
P1476
Circulating lipocalin-2 and re ...... patients with type 2 diabetes
@en
P2093
P2860
P304
P356
10.1371/JOURNAL.PONE.0066607
P407
P577
2013-06-17T00:00:00Z